Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX–Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective–Prospective StudyAntonio Coppola, Annarita Tagliaferri, Gabriele Quintavalle et al.|Journal of Clinical Medicine|2024Cited by 6